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Abstract
Background: Estrogen receptors (ER) have important physiological roles in both the female and
male reproductive systems. Previous studies using the estrogen receptor-α knockout mouse
(αERKO) or antiestrogen treatment in adult rodents have shown that ERα is essential for normal
function of the male reproductive tract. In the present study, time-response effects of the
antiestrogen ICI 182,780 were determined to better understand ERα function in the adult male.
Methods: Adult male mice, 30 days old, were injected subcutaneously with ICI 182,780 (5 mg)
once per week for 17 weeks. Tissues were fixed by vascular perfusion to study the time responses
from day 2 to 125 post treatment.
Results: No difference was seen in body weight due to treatment. Testis weight was decreased
18% on day 59 and 21.4% on day 125. Other significant treatment-related effects included the
following: 1) dilation of rete testis and efferent ductule lumen; 2) decreased height of the rete testis
and efferent ductule epithelium; 3) decreased height of the supranuclear epithelial cytoplasm in
efferent ductules; 4) decreased height of the efferent ductule epithelial microvilli, particularly in the
proximal ductules; 5) decrease in the PAS-positive granules and endocytotic vesicles in nonciliated
epithelial cells of efferent ductules; 6) capping and vesiculation of narrow cells in the initial segment
of the epididymis; 7) accumulation of PAS-positive granules in apical cells of the caput epididymis;
8) increase in lysosomal granules in clear cells of the corpus and cauda epididymis; 9) limited
induction of atrophic seminiferous tubules and abnormal spermatogenesis; and 10) decreases in the
concentration of cauda sperm, progressive sperm motility and decreased fertility.
Conclusions: Antiestrogen treatment of the pubertal male mouse resulted in reproductive effects
similar to those observed in the αERKO mouse as early as day 4; however, testis weight did not
increase substantially and total atrophy was not observed with extended treatment.
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The estrogen receptor (ER)-α knockout mouse (αERKO)
was the first animal model to clearly demonstrate the
importance of estrogen in male reproductive tract func-
tion and fertility [1–10]. The double knockout of ERα and
ERβ [10] and the more complete ERα knockout [3] con-
firmed that ERα is the major receptor responsible for
estrogen function in male reproduction.
The major histopathological effect of ERα knockout in the
male mouse reproductive tract was centered in the efferent
ductules, a small region between the testis and initial seg-
ment of the epididymis [4,5,11]. In the αERKO male,
there was a failure of efferent ductule epithelium to reab-
sorb fluid, which caused fluid to accumulate in the rete
testis and seminiferous tubule lumen. The long-term con-
sequence of this pathophysiology was backpressure atro-
phy of the testis, which lead to azoospermia. The
important role of estrogen in the male reproductive tract
was further demonstrated by transplanting αERKO testic-
ular germ cells into a wild-type recipient mouse testis
depleted of germ cells [12,13]. The transplanted αERKO
germ cells gave rise to offspring, thus demonstrating that
αERKO sperm are capable of fertilizing eggs if the sperm
travel through a wild-type reproductive tract
environment.
The αERKO mouse continues to be an important animal
for the study of estrogen receptor function in the male, but
this transgenic animal is a developmental model, as the
males lack ERα expression throughout perinatal and post-
natal life. Therefore, to test the hypothesis that ERα is nec-
essary in the adult male, and not just for development, the
pure antiestrogen ICI 182,780 (AstraZeneca, Macclesfield,
Cheshire, UK) was used to block ERs in the pubertal male.
In the first study, mice were treated for 35 days and exam-
ined for effects. In general, it was concluded that ICI
182,780 treatment replicated most of the effects seen in
the αERKO male, except for testicular atrophy and infertil-
ity [9].
The rat was also studied for comparison, and although
there were similarities to the ICI 182,780 treated mouse,
i.e., dilation of rete testis and efferent ductule lumen and
decreased height of the ductal epithelium, the time-
response approach used in the rat revealed considerable
differences between the two species in response to the
antiestrogen [14,15]. The rat showed long-term testicular
atrophy induced by fluid accumulation and testicular
swelling, which led to infertility, similar to the αERKO
male. Testicular and efferent ductule effects in the rat were
rapid, beginning within 2–4 days after treatment. The rat
efferent ductule epithelium also displayed an unusual
increase in lysosomal content in the apical cytoplasm of
the nonciliated cells, a response not noted after 35 days of
treatment in the mouse [9]. Therefore, several questions
remained regarding antiestrogen responses in the mouse
model: a) Does the mouse require a longer treatment
period to show testicular atrophy? b) Is the rat more sen-
sitive to the antiestrogen? c) Would a longer treatment
period in the mouse lead to infertility? To answer these
and other questions, a time-response study of ICI 182,780
treatment in pubertal male mice was conducted over a 17-
week period.
Materials and Methods
Animals and experimental design
This study was conducted in three experiments to fully
cover the response period to antiestrogen treatment. The
first experiment examined days (d) 8–59 post treatment.
Because strong effects were found on d 8, a search for the
first response was conducted in an experiment that exam-
ined days 1, 2 and 4 post treatment. Infertility was not
observed on d 59, therefore, a third experiment was per-
formed to test for effects on days 100 and 125 post
treatment.
Adult male C57BL/10 mice at 30 days of age were main-
tained under constant lighting (12 h light:12 h dark) and
temperature (22°C). The University of Illinois Institu-
tional Animal Care and Use Committee approved all
experimental protocols. Food and water were available ad
libitum for the experimental period. Animals were ran-
domly divided into control (N = 3–6) and treated (N = 3–
6) and injected subcutaneously with 0.1 ml of castor oil
(controls) or 5 mg of ICI 182,780 (AstraZeneca, Maccles-
field, UK) in 0.1 ml, each week for up to 125 days.
Tissue processing
Control and ICI-treated mice were euthanized at specified
time points out to d 125 post treatment. The animals were
deeply anesthetized with xylazine/ketamine (87 mg/kg
and 15 mg/kg, respectively), weighed, and then fixed by
vascular perfusion with 4% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4) for Histopathology. Bouin's
fixative or neutral buffered formalin was perfused for
immunohistochemistry. Testes, efferent ductules and the
epididymides were removed and stored in the same per-
fusion solution at 4°C until embedded. For microscopic
evaluation, tissues were weighed and then washed in
cacodylate buffer, dehydrated in an ascending series of
ethanol and embedded in glycol methacrylate (Hess et al,
2000). Tissue blocks were cut at 2.5 µm thickness, dried at
35°C, stained with periodic acid-Schiff reaction (PAS),
counterstained with Mayer's hematoxylin and mounted
for observation. Cauda epididymal sections were also
stained with Coomassie blue G250, which highlights the
sperm acrosome blue and the nucleus pink.Page 2 of 17
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Immunohistochemistry was performed only on the effer-
ent ductule tissues, because of its previously determined
significance in the αERKO male [4,5,7]. Staining followed
previously reported methods of antigen retrieval and indi-
rect secondary antibody labeling [7,16]. Antibodies
included, rabbit anti-human carbonic anhydrase-II (CA-
II; Chemicon International. Temecula, CA) diluted
1:1000; rabbit anti-rat sodium/hydrogen exchanger-3
(NHE3;Chemicon International. Temecula, CA) diluted
1:1000; rabbit anti-rat aquaporin-1 (AQP1) diluted
1:1000; anti-human ERα (NCL-ER-6F11; Novocastra,
Newcastle upon Tyne, UK) diluted 1:1000; sheep anti-
human ERβ. [S-40, [17]]; and rabbit anti-rat AR diluted
1:500 [PG21, [18,19]]. Antibody binding was visualized
using the avidin-biotin complex (ABC Kit, Vector Labora-
tories, Burlingame, CA) and diaminobenzidine (DAB).
Hematoxylin was applied as a counter stain (Sigma, St.
Louis, MO). Sections incubated without the primary anti-
body but with PBS were used as negative controls for color
development on the same slide. Images were captured
with a Spot II digital camera (Diagnostic Instruments, St.
Sterling Heights, MI) and compiled using Adobe® Pho-
toshop® (Adobe Systems, San Jose, CA).
Sperm Concentration and Motility
To determine sperm concentration in the cauda epidi-
dymis for the first 59 days of the study, paraffin histolog-
ical sections of the distal cauda epididymis were sectioned
at 20 µm thickness and stained with hematoxylin and
eosin. The slides were viewed using a video camera
mounted on an Olympus microscope with a plan-
apochromatic 100X objective. Observed fields were
selected by a systematic, uniform random sampling
method, using the Stereo Investigator software, v3.0
(MicroBrightField Inc., Colchester, VT) and a motorized
stage. Sperm heads were counted in a counting frame hav-
ing a total of 20,000 µm3 per tubule. Ten replications per
epididymis were made.
On day 125 post treatment, sperm concentrations were
determined using minced cauda epididymides and a dual-
sided semen analyzer system (Hamilton Thorne Research,
Beverly MA). The cauda epididymis on one side of the 125
day mouse was dissected prior to perfusion and was
placed in a sterile Petri dish containing 1 ml of modified
Hank's Balanced Salt Solution (m-HBSS) for sperm motil-
ity analysis. The cauda was minced and incubated for 5
minutes at 37°C to allow sperm to swim into the media.
At the end of the incubation time, a 100 µl sample of the
media containing the sperm was diluted with 900 µl of
the m-HBSS solution for sperm analysis. Each sperm anal-
ysis chamber was loaded with 14 µl of the diluted sperm
by capillary action. Analysis chambers were immediately
placed into the specimen holder of TOX-IVOS computer
assisted sperm analysis system that had been calibrated
for mouse sperm samples. The samples, chambers and
specimen holder were maintained at 37°C throughout
the entire measurement period. Six fields were analyzed
from each of the two chambers and the results averaged.
Image analysis
Tissues were photographed using a Spot-II digital camera
mounted on an Olympus Microscope and Plan-apochro-
matic lenses (Olympus America Inc, NY) and saved in
Adobe Photoshop (Adobe Systems, Inc., San Jose, CA).
Morphometry data from days 8, 16, 59 and 125 post treat-
ment are included. The digital images from both repro-
ductive tracts of 3 control and 3 ICI-treated animals on
each post treatment day were analyzed by Scion Image
Software (Scion Corporation, Frederick, MD). Luminal
diameter of 10 seminiferous tubules (stages VII-VIII) was
determined per mouse per testis, by measuring the widest
diameter in cross-section. However, for day 125 all sem-
Table 1: Effects of ICI 182,780 on body and testis weight.a
Testis Weight (mg)
Day of treatment Body Control Weight (g) ICI-Treated Control ICI-Treated
8 17.99 ± 2.22 19.8 ± 1.17 71.4 ± 1.81 83.2 ± 5.87
10 16.48 ± 0.81 22.66 ± 0.42 68.0 ± 2.96 78.9 ± 4.33
12 19.74 ± 1.58 24.41 ± 1.43 85.1 ± 2.49 90.9 ± 0.86
14 22.17 ± 0.98 21.57 ± 0.15 91.0 ± 3.40 91.0 ± 2.93
16 22.65 ± 0.46 24.3 ± 0.15 84.9 ± 1.40 96.3 ± 1.70b
25 25.67 ± 0.66 26.11 ± 0.56 96.5 ± 2.59 94.6 ± 2.85
59 26.63 ± 0.44 30.19 ± 1.27 128.7 ± 5.37 105.0 ± 7.03b
125 29.97 ± 0.45 31.97 ± 0.78 95.2 ± 2.58 74.8 ± 4.75b
a Values are mean ± SEM b p < 0.05.Page 3 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/57Testis sections on day 125 from control (A) and ICI 182,780 treated mice (B)Figure 1
Testis sections on day 125 from control (A) and ICI 182,780 treated mice (B). Control testis shows normal spermatogenesis 
with seminiferous tubules (ST) filled with germ cells. In the treated testis, several tubules (ST) show normal spermatogenesis, 
but other show abnormal spermatogenesis (Ab) and two tubules are atrophic (*). The abnormal tubules show decreases in 
spermatids, sometimes only in portions of the epithelium. Bar = 100 µm.Page 4 of 17
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because some tubules were atrophic and stage of sperma-
togenesis was not determined. Luminal diameter of the
rete testis was determined in 3 testes per treatment group.
Luminal diameter of proximal efferent ductules was deter-
mined in 5 sections per mouse. Cell height was measured
from the base to the apex in 30 epithelial cells of the rete
testis region, or to the microvillus tip in 30 nonciliated
cells from non-oblique sections of the proximal efferent
ductules per mouse. The supranuclear cytoplasmic height
was determined by measurement from the top of the
nucleus to the microvillus tip in the nonciliated cells in
the proximal efferent ductules.
Fertility
Individual mice of control and ICI-treated groups on day
50, day 93, or day118 after treatment were mated with 3
female mice of the same age and strain for one week, then
separated. One week after separation, the females were
euthanized by sodium pentobarbital injection and the
uterine horns opened. The number of embryos, number
of implantation sites and resorptions/stillbirths were
counted. If at least one female per mating had live births,
the male was considered fertile. Subfertility was indicated
by a reduction in the number of live births or an increase
in the number of resorptions.
Statistical analysis
Data are presented as means ± SEM. To compare morpho-
logical differences between controls and treatment
groups, means were analyzed by two-way ANOVA fol-
lowed by individual paired t-test for each time point (P <
0.05). Proportion data were analyzed by the chi-square
test with a probability of less than 5% considered
significant.
Results
Body and organ weights
There was no significant difference in body weight
between control and the treated groups (Table 1). Testis
weight was increased on day 16 but decreased on days 59
and 125. The increase in weight on day 16 is likely due to
a discrepancy in animal ages at the time of treatment.
When this time point was repeated using mice at 30 day
of age, the difference disappeared (data not shown).
Testis and rete testis
Spermatogenesis appeared normal until day 59, as which
time focal regions showed seminiferous epithelial disrup-
tion and the beginning of isolated tubular atrophy. How-
ever, normal spermatogenesis was seen in most
seminiferous tubules throughout the 125-day treatment
Seminiferous tubular atrophyFigure 2
Seminiferous tubular atrophy. Even control testes show lim-
ited atrophic tubules with aging of the males, but beginning 
on day 59 the number of atrophic tubules was significantly (*) 
increased in the ICI-treated testes. Means ± SEM; (p < 0.05).
Rete testis luminal diameterFigur  3
Rete testis luminal diameter. The antiestrogen treatment 
model induced a highly significant increase in the diameter by 
day 59 (p < 0.05).Page 5 of 17
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Rete testis histology from control and ICI-treated groups on day 59 post treatment. A. Control rete testis filled in with black 
shading to show a very thin channel (RT) with seminiferous tubule on the left (ST). B. Higher magnification of control showing 
a nearly cuboidal epithelium with narrow lumen (double arrow). The side adjacent to the tunica albuginea (TA) was thinner 
than the side adjacent to the seminiferous tubules. C. ICI 182,780 treated rete testis (RT; filled with black shading) showing 
strong dilation (double arrow). Seminiferous tubules (ST) are normal. D. ICI treated rete epithelium that is decreased in height 
(arrow). Bar = 100 µm for A, C. Bar = 25 µm for B, D.Page 6 of 17
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difference between treatment groups until day 125, when
mean tubular diameter in the treated group was 164.8 ±
0.8 µm compared to 187.1 ± 4.0 µm for the controls, a sig-
nificant difference of 11.9% (p < 0.01). This change was
due to a significant increase in the number of atrophic
seminiferous tubules from day 59 to 125 (Fig. 2). The
luminal diameter of rete testis was increased 241% on day
59 in the treated group (Figs. 3 and 4A,4B,4C,4D) and
remained dilated throughout the 125-day period. Epithe-
lial cells lining the rete testis were variable in height, but
showed significant decreases (22% overall decrease across
all time periods) beginning on day 8 and continuing to
day 125 (Figs. 4B,4D).
Efferent ductule
As early as day 4 post treatment, ICI 182,780 treatment
caused luminal dilation in the proximal efferent ductules
(Fig. 5). However, luminal dilation on day 4 was noted
without a decrease in epithelial height. Tubule dilation
continued throughout the treatment period, reaching a
maximum increased dilation of 140% on day 125 (Fig. 6).
The conus and common efferent ductules also showed sig-
nificant dilation at all time points (data not shown).
Height of epithelial cells in the efferent ductules was also
decreased after treatment on days 8–125 (Fig. 7); how-
ever, on day 125 epithelial height was highly variable in
the treated males and the mean was approaching that of
the controls, although areas were nearly squamous in
appearance (Fig. 8).
Proximal region of efferent ductules from control (A, C) and ICI-treated (B, D) groups on day 4 post treatmentFigure 5
Proximal region of efferent ductules from control (A, C) and ICI-treated (B, D) groups on day 4 post treatment. A. Control 
efferent ductules have a narrow diameter (double arrows). B. ICI treated ductules are dilated (double arrows) extensively by 
day 4. C-D. Higher magnification shows no change in the epithelium on day 4 post treatment. Bar = 50 µm for A, B. Bar = 25 
µm for C, D.Page 7 of 17
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abundant endocytotic apparatus in nonciliated cells of the
efferent ductule, was consistently reduced by nearly 50%
in the treated group, compared to controls (Fig. 9). On
day 125, the supranuclear region was increased in both
treated and controls, but there still remained a significant
reduction in height in some proximal ductule areas (Fig.
8).
PAS positive lysosomal granules were numerous in the
supranuclear cytoplasm of control nonciliated cell in the
proximal region (Fig. 8A,8C,8E). The conus and common
regions in control animals contained fewer lysosomal
granules (data not shown). ICI 182,780 treatment caused
a reduction in the number of lysosomes and vesicles in all
regions, but in some regions the effect was more dramatic
(Fig. 8B,8D,8F). The reduction in lysosomes was associ-
ated with a decrease in supranuclear cytoplasm (Fig. 9).
With decreased height of the epithelium, the nuclear
shape was changed from nearly round or slightly colum-
nar (controls) to a more flattened morphology (Fig. 8).
ICI 182,780 treatment also caused microvilli along the
luminal border of the nonciliated cell to shorten signifi-
cantly (Fig. 10). Mean height of microvilli in the treated
tissue was decreased by 18% in the proximal efferent duc-
tule epithelium. Microvilli in the conus and common
regions were decreased in height by 16% and 6%, respec-
tively (data not shown).
Efferent ductule immunohistochemistry
On day 125 post treatment, the expression of ERα was
decreased, while ERβ showed no change in expression in
the efferent ductule epithelium (Fig. 11A,11B,11C,11D).
NHE3 was completely absent along the apical border of
the treated nonciliated cells (Fig. 11E,11F). AQP1 were
decreased significantly along the apical border in noncili-
ated cells of the ICI 182,780 treated efferent ductules, but
along the basolateral border all staining was eliminated
(Fig. 11G,11H). CAII was also decreased significantly
along the apical cytoplasm of the efferent ductule epithe-
lium (Fig. 11I,11J).
Proximal efferent ductule luminal diameterFigure 6
Proximal efferent ductule luminal diameter. The ductule 
lumen was dilated significantly throughout the treatment 
period. Means ± SEM. Significant differences (*) between con-
trol and treated at each time point are noted (p < 0.05).
Proximal efferent ductule epithelial cell heightFigure 7
Proximal efferent ductule epithelial cell height. Cell height 
was reduced significantly at all time points. However, on day 
125 post treatment the mean difference was less than previ-
ous periods and the height showed greater variation. Means 
± SEM (p < 0.05).Page 8 of 17
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Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/57Higher magnification of the proximal efferent ductule epithelium in control (A,C,E) and ICI-treated (B,D,F) malesFi ure 8
Higher magnification of the proximal efferent ductule epithelium in control (A,C,E) and ICI-treated (B,D,F) males. A, B. Day 12 
post treatment showing nearly cuboidal epithelium in control tissue during early puberty but a shortened epithelium in the ICI 
treated (B). Ci, cilia; Mv, microvilli; V, endocytotic vesicles. C, D. Day 59 post treatment the epithelium has reached it maxi-
mum height in control samples (C), however, the height is quite variable between regions. Nuclei (Nu) of ciliated cells are 
found more apical than the nonciliated cells. Apical cytoplasm of nonciliated cells contained an abundance of PAS-positive gran-
ules, previously identified as lysosomes (arrows). Microvilli (Mv) are tall and easily distinguished from the long cilia (Ci). In the 
ICI-treated ductules, microvilli are short and the nuclei are flattened. E,F. Day 125 post treatment. The control ductule epithe-
lium is columnar (double arrow) and contains numerous PAS-positive granules. In some regions of the ICI-treated group, the 
epithelium remains severely shortened in height (double arrow). Bar = 50 µm for A, B. Bar = 25 µm for C-F.Page 9 of 17
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In the initial segment, narrow cells show slight protrusion
of their apical vesiculated cytoplasm into the lumen,
while in the ICI 182,780 treated tissues the narrow cell
cytoplasm contained more vesicles and protruded further
into the lumen (Fig. 12). By day 125 post treatment, api-
cal cells in the caput epididymis were engorged with PAS-
positive lysosomal-like granules (Fig. 13), with some
granules nearly as large as the nucleus. In the corpus and
cauda regions post treatment, the clear cells showed an
increase in the number and size of vesicles in both princi-
pal and the clear cells (Fig. 14). This observation was
present as early as day 8 post treatment. The vesicles were
mainly supranuclear in location. Clear cells also con-
tained an increase in the number of PAS positive granules
in their basal cytoplasm after treatment (Fig. 14). After
antiestrogen treatment, principal cells of the distal cauda
also showed an increase in the number and size of cyto-
plasmic vesicles, as early as day 8, as well as an increase in
the number of PAS-positive granules (Fig. 14).
Histological sections of cauda epididymis on day 59 post
treatment were also stained with Coomassie blue G250 to
highlight the sperm acrosome and nucleus. Several abnor-
malities were noted in the ICI-treated sections (Fig. 15). In
control cauda epididymis, the sperm were aligned nearly
parallel and the cytoplasmic droplet was located on the
mid-tail region. At higher magnification, the sperm heads
were attached to the tail and displayed a prominent stain-
ing of the acrosomic region along the dorsal edge of the
nucleus (Fig. 15A,15B). In the ICI-treated samples, sperm
were less concentrated and appeared disorganized, with
few nuclei attached to tails (Fig. 15C). At higher
magnification, detached sperm nuclei were misshaped
and often appeared to have reduced staining of the acro-
some (Fig 15D,15E) and the tails were looped around the
cytoplasmic droplets (Fig. 15F).
Proximal efferent ductule nonciliated cell supranuclear cyto-plasmic h ightFigure 9
Proximal efferent ductule nonciliated cell supranuclear cyto-
plasmic height. The data represent means ± SEM. The 
increase seen on day 125 may be due to this day being a sep-
arate experiment, although there may be some increase due 
to aging. Significant differences (*) between control and ICI-
treated means are noted (p < 0.05).
Proximal efferent ductule nonciliated cell microvillus heightFigure 10
Proximal efferent ductule nonciliated cell microvillus height. 
The data represent means ± SEM. At all time points there 
was a significant decrease in height (*) between control and 
ICI-treated cells (p < 0.05).Page 10 of 17
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Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/57Immunohistochemical staining of proximal efferent ductules on day 125 post treatmentFigure 11
Immunohistochemical staining of proximal efferent ductules on day 125 post treatment. A,B. ERα is expressed abundantly in 
control efferent ductule epithelium, with slightly less staining in the ciliated cells (apical nuclei), but is reduced in the ICI-treated 
tissue. C,D. ERβ is also abundant in efferent ductule epithelial cells, both in the controls and treated samples. E,F. Sodium/
hydrogen exchanger (NHE3) is stained heavily along the apical border of the nonciliated cells of control tissue, but is absent in 
the ICI-treated tissue. G,H. Aquaporin-1 (AQP-1) is abundant along the microvillus border of the control ductules, but is 
diminished in the treated tissue, although intensely stained along the apical border of some cells. I,J. Carbonic anhydrase II 
(CAII) is present along the microvillus border and in apical cytoplasm of control ductules, but is greatly reduced in the epithe-
lium of treated tissues. Bar = 25 µm.Page 11 of 17
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There was no difference in fertility, the number of
embryos or the number of resorptions and stillbirths per
female between the control and treated groups on day 59
and 100 (data not shown). However, cauda sperm con-
centrations in the treated groups did not show the normal
increase associated with increasing age and beginning on
day 16 through 125 post treatment there was a significant
difference from controls (Fig. 16). On day 125 post treat-
ment, cauda sperm concentration in the ICI-treated males
was decreased 40%, sperm motility was decreased 80%
and 4 of 6 treated males were infertile (Table 2). The
treated males that sired offspring had a lower mean
number of births (litter size), but due to large variation in
both groups, the means were not significantly different.
However, there a significant increase in the incidence of
resorptions and stillbirths (Table 2).
Discussion
The present study demonstrates that the mouse ICI
182,780 treatment model, when extended from 4 days to
125 days post treatment, resembles the αERKO model in
nearly every feature, except for the transient increase in
testis weight and testicular atrophy. The decrease in sperm
concentration in cauda epididymis and luminal dilation
of the rete testis and efferent ductules following treatment
clearly support the overall hypothesis that a functional
ERα is required for normal fluid reabsorption in the effer-
ent ductules, as concluded from prior studies of the
αERKO male [4,7].
In the present model, treatment was started at 30 days of
age. This age represents early puberty and the males were
still growing, as evidenced by the increase in body and tes-
tis weights in controls and treated animals over the next
60 days. Except for an unexplained difference in testis
weight on day 16 post treatment, there was no effect on
testis weight out to day 25, similar to a previous short-
term study [9]. However, on day 59 of treatment testis
weight differences began to appear, with a decrease in the
treated animals. Thus, with a longer treatment period the
mouse showed limited atrophy of seminiferous tubules,
but not total atrophy as seen in the αERKO males [4].
Initial segment of the epididymis on days 10 and 59 post treatmentFigure 12
Initial segment of the epididymis on days 10 and 59 post treatment. A. Control section on day 10 showing the narrow cell 
(NC), whose apical cytoplasm protrudes (arrow) into the lumen. Principal cell (PC) nuclei lie beneath the narrow cell. B. ICI 
182,780 treated section on day 10 showing two narrow cells with more extensive apical cytoplasmic vesiculation extending 
into the lumen (arrows). C. Control day 59 showing normal epithelium with narrow cells having a modest extension into the 
lumen (arrow). D. ICI-treated day 59 showing a narrow cell extension (arrow) into the lumen, similar to that seen on day 10. 
Bars = 12.5 µm.Page 12 of 17
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Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/57At the beginning of puberty, spermatogenesis appears
normal in the αERKO testis, but as the male ages seminif-
erous tubules begin to degenerate [1]. The αERKO testis
weight nearly doubles in approximately 40 days, starting
at puberty; then testis weight declines and eventually total
testicular atrophy occurs at 185 days of age [4]. ICI
182,780 treatment in the rat induces a similar pattern of
effect, with both testicular swelling and long-term atrophy
of the testis, nearly identical to the αERKO male [14,15].
Why the mouse testis did not respond with a similar
increase in testis weight and then atrophy remains a major
question. However, the rete testis was dilated in the
mouse, as in αERKO and ICI-treated rat males, suggesting
that ability of the mouse testis to handle fluid accumula-
tion is dependent upon developmental factors that are
lacking in the αERKO male. One possibility is that the
mouse epididymis is capable of compensatory reabsorp-
tion of the excess fluid. Future studies are required to
understand these differences in response.
The effects observed on spermatogenesis did not appear to
be due to fluid accumulation because there was no dila-
tion of the seminiferous tubular lumen, in contrast to
what was discovered in the αERKO testis [4].
Furthermore, abnormal spermatogenesis did not occur
until day 59, suggesting that the degenerative process
required long-term inhibition of ER. Because ICI 182,780
blocks both ERα and ERβ [20], the delayed testicular
response may be due to ICI's inhibition of ERβ and not
ERα. ERα is not expressed in the seminiferous epithelium,
but ERβ is abundant in Sertoli and germ cells [16,21–25].
Therefore, ICI's effects on the epithelium may be through
long-term inhibition of ERβ. It is interesting that the
aromatase knockout mouse also shows a delayed disrup-
tion of spermatogenesis [26,27], similar to the effects of
ICI 182,780 in the mouse testis. Although the ERβ knock-
out mouse shows no apparent phenotype [3,10,28], in
light of the current findings, it would be worthwhile to
examine the βERKO male for specific aging effects on the
testis.
Dilation of the rete testis lumen was less extensive follow-
ing ICI 182,780 treatment, compared to the αERKO
mouse [9]. The present study demonstrated that this effect
begins sooner than previously thought, with dilation
being observed on day 10. On the other hand, the rete
Caput epididymis on day 125 post treatmentFigure 13
Caput epididymis on day 125 post treatment. A. Control caput showing the apical cell (Ac) with and without apical PAS-posi-
tive granules. B. ICI-treated caput region showing increased number of the apical cells (arrows) that are engorged with PAS-
positive granules. C. Higher magnification of ICI-treated caput region showing an increased size of the PAS-positive granules 
(large arrows) and the appearance of granules below the nucleus (small double arrows). Bars = 25 µm for A and C. Bar = 100 
µm for B.Page 13 of 17
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Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/57epithelium was reduced in height as early as day 8. It is
assumed that the decrease in epithelial height is related to
the accumulation of luminal fluid; however, it may also
be due to overgrowth of the rete epithelium because
neonatal exposure to environmental estrogens has pro-
duced a similar dilation and overgrowth of the rete testis
[29,30].
A prior study did not find these early effects of ICI
182,780 treatment [9]. However, here we report effects as
early as day 4, at which time proximal regions of the effer-
ent ductules were dilated. This observation is important
because the dilatation did not induce a reduction in epi-
thelial cell height, suggesting that the two effects are not
directly linked. Others have suggested that the decrease in
epithelial height is due to alterations in ion transporter
Corpus and cauda regions of the epididymis from control (A,C) and ICI-treated (B,D) males on day 8Figure 14
Corpus and cauda regions of the epididymis from control (A,C) and ICI-treated (B,D) males on day 8. A. Corpus epididymis in 
control. PAS-positive granules (arrow) are distributed in the perinuclear region of a clear cell (CC) that also contains a few api-
cal vacuoles. Sperm (Sp) appear normal in the lumen. B. Corpus epididymis in ICI-treated. The clear cell appears to contain an 
increased number of apical vesicles and basal granules (arrow). Sperm appear normal in the lumen on day 8. C. Cauda epidi-
dymis in control. PAS-positive granules (arrow) are abundant in the perinuclear region of a clear cell. The principal cells (PC) 
have small vacuoles in the cytoplasm. Sperm (Sp) appear normal in the lumen. D. Cauda epididymis in ICI-treated. PAS-positive 
granules (large arrow) are more abundant in the basal region of a clear cell. There is an increase in the number of cytoplasmic 
vacuoles in the principal cells (small arrows). Sperm (Sp) appear normal in the cauda lumen on day 8. Bars = 25 µm for A, B. 
Bars = 12.5 µm for C, D.Page 14 of 17
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hypothesis, as fluid reabsorption detected by luminal
dilation occurred without a decrease in epithelial height.
Other early effects were subsequent reduction in efferent
ductule epithelial height (day 8) and protrusion of the
narrow cells in the epididymis. Effects on the testis were
not observed until much later. These early morphological
effects were maintained throughout the 125-day treat-
ment period and are in agreement with our previous stud-
ies of αERKO mouse [4,5] and ICI 182,780 treatment in
mice [9]. Thus, it may be possible to use the mouse anti-
estrogen treatment model during shorter periods of treat-
ment for the study of fluid dynamics within the efferent
ductules, but also to study testicular effects that require
more than 50 days of exposure.
Overall effects of ICI 182,780 on the mouse efferent duc-
tules were identical to those observed in the αERKO male,
including the loss of NHE3 staining and decrease in
staining for AQP-1 and CAII [7]. These data further sup-
port the hypothesis that estrogen's regulation of sodium
transport by this epithelium is essential for maintenance
Table 2: Reproductive performance in mice after antiestrogen treatmenta.
Parameter Control ICI-Treated
Percent Progressive Sperm Motility 34.5 ± 2.90% 7.2 ± 3.11%b,c
Fertile males 6/6 2/6d
Average litter size 8.0 ± 0.8 5.80 ± 1.3e
Percentage of Resorptions/fetal deaths 12.3 ± 1.1% 20.67 ± 1.7%c
a N = 6 per group; mice were 118 days of age for fertility trials; 155 days of age at sacrifice. b Values are mean ± SEM c p < 0.05 by the chi-square 
test. d 4 of 6 males were infertile; subfertility was indicated by an increase in resorption in the 2 males that were fertile. e Not significantly different; 
p = 0.21 by t-test.
Cauda epididymal region on day 59 stained with Coomassie blue G250 to highlight the sperm acrosome and nucleusFigure 15
Cauda epididymal region on day 59 stained with Coomassie blue G250 to highlight the sperm acrosome and nucleus. A. Con-
trol section showing normal spermatozoa (arrow) with intact sperm tails and normal heads. Cytoplasmic droplets (*) are found 
along the mid-tail region. Sperm are aligned nearly parallel within the lumen. B. Higher magnification of a normal sperm from 
the control section showing an intact acrosome (arrows) along the dorsal edge of the sperm nucleus (pink stain). C. ICI-
treated section showing more dilute sperm, isolated sperm heads (circles), disorganized appearance and sperm tails looped 
around the cytoplasmic droplets (*). D, E. higher magnification of ICI-treated sperm heads showing abnormal shapes (arrow) 
and decreased staining of the acrosome region. F. Higher magnification of the tail looped around cytoplasmic droplets 
(arrows). Bars = 10 µm for A, C. Bars = 2.5 µm for B, D, E, F.Page 15 of 17
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a decrease in ERα staining, which has been reported in
female tissues [31], but the compound had no effect on
ERβ.
The effects noted in epididymis could be due to direct
action of ICI on the epididymal epithelium, as recent
studies have shown that ERα is expressed more
extensively in the epididymis of the mouse [21], than in
the rat [11]. Cell types that responded to treatment, the
narrow and apical cells of initial segment, apical cells of
the caput, and clear cells of the corpus and cauda, are all
strongly ERα-positive [21]. In the ICI treated group, apical
vesicles in the narrow cells and vesicles in clear and prin-
cipal cells in corpus and distal caudal epididymis were
increased in size and number. An accumulation of large
PAS-positive granules was also observed in the apical cells
of the caput. These findings are nearly identical to epidi-
dymal changes seen in αERKO [5] and may indicate an
attempt to increase reabsorption of fluid by the epidi-
dymis, to compensate for reduced reabsorption found in
the proximal region of the efferent ductules [4,7].
In the control animals, epididymal sperm concentrations
reached their peak on day 59, showing a gradual increase
starting at 38 days of age. However, the ICI treated group
did not experience this normal increase in sperm concen-
tration and beginning on day 16 showed a divergence
from controls so that on days 59 and 125 post treatment
there were decreases of 30 and 41%, respectively. These
differences are considerably more than the 22% decline
seen in αERKO males [9]. On day 25 (data not shown),
there was a 12.4% decline in sperm concentration, which
was similar to our previous experiment, which showed an
11% decrease after 35 days of antiestrogen treatment [9].
Thus, the overall trend in the mouse antiestrogen treat-
ment model is for increasing dilution of cauda sperm and
accumulation of fluids in the efferent ductules and testis.
It is noteworthy that the decrease in fertility did not occur
until day 125 post treatment, the time period that coin-
cided with the maximum decrease in sperm concentra-
tion. In the rat, decreased fertility coincided with the onset
of testicular atrophy [14,15], therefore it was questioned
whether infertility and subfertility was due to abnormal
sperm maturation due to dilution in the epididymis or if
atrophy of the seminiferous epithelium was required
before sperm concentrations could reach levels that
would produce infertility. The current study suggests that
subfertility in the mouse antiestrogen treatment model is
related to the sperm dilution effects that occur in the
epididymis, which appears to induce abnormal matura-
tion of the cauda sperm. Even in the αERKO male, testic-
ular sperm are fertile when transplanted into germ cell
depleted normal testes [12,13], which suggests that the
epididymal environment is one of the more important
factors leading to infertility in the absence of ERα expres-
sion in the male.
Conclusions
The antiestrogen, ICI 182,780 induces very early effects on
rete testis, efferent ductules and epididymis, which resem-
ble morphological changes observed in the αERKO male.
These early effects are maintained throughout the treat-
ment period of 125 days and thus, suggest that a much
shorter model of 4–8 days of treatment may be used to
study the role of estrogen in fluid reabsorption in the male
tract. Although the inhibition of estrogen receptors for
125 days induced structural and physiological changes in
the reproductive tract, it did not induce total testicular
atrophy, but did cause a decrease in fertility and showed
evidence of early induction of abnormal spermatogenesis.
Thus, it is possible to induce infertility by blocking ER
function in the male, without causing azoospermia. If
such treatment effects are observed at lower dosages and if
the responses are reversible, it should be possible in the
future to target ERα for male contraception.
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